Clinical trial
A Phase I Trial of PVSRIPO for Patients With Unresectable Melanoma
NCT03712358 is registered in ClinicalTrials.gov with Istari Oncology, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase I Trial of PVSRIPO for Patients With Unresectable Melanoma
- Lead sponsor
- Istari Oncology, Inc.
- Phase
- Phase 1
- Overall status
- Terminated
- Start date
- November 26, 2018
- Completion date
- March 23, 2021
- Enrollment
- 12 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.